Drugs for Treatment of Vulvovaginal Candidiasis: Comparative Efficacy of Agents and Regimens
- 1 November 1990
- journal article
- research article
- Published by SAGE Publications in DICP
- Vol. 24 (11) , 1078-1083
- https://doi.org/10.1177/106002809002401112
Abstract
Various agents are available for the treatment of vulvovaginal candidiasis. Imidazole agents (clotrimazole, miconazole, butoconazole, and terconazole) are preferred because of their greater efficacy, shorter treatment regimens, and ease of administration. Although the various imidazole compounds are equaly efficacious, different treatment schedules are recommended depending on clinical situations. Additionally, different formulations are available that provide clinicians and patients with the opportunity to select the most appropriate agent.Keywords
This publication has 39 references indexed in Scilit:
- Oral versus local treatment of vaginal candidosisInternational Journal of Gynecology & Obstetrics, 1989
- Therapy of candidal vaginitis: The effect of eliminating intestinal CandidaAmerican Journal of Obstetrics and Gynecology, 1986
- Epidemiology of Recurrent Vulvovaginal Candidiasis: Identification and Strain Differentiation of Candida albicansThe Journal of Infectious Diseases, 1986
- Anticandidal activities of terconazole, a broad-spectrum antimycoticAntimicrobial Agents and Chemotherapy, 1986
- Epidemiology and pathogenesis of recurrent vulvovaginal candidiasisAmerican Journal of Obstetrics and Gynecology, 1985
- Repeated candidiasis: Reinfection or recrudescence? A reviewAmerican Journal of Obstetrics and Gynecology, 1985
- VaginitisAmerican Journal of Obstetrics and Gynecology, 1985
- Recurrent Candida VulvovaginitisChemotherapy, 1982
- On the Action Kinetics of ClotrimazoleChemotherapy, 1982
- The Antifungal Imidazoles: Clotrimazole and MiconazoleScottish Medical Journal, 1978